GLAZER CAPITAL, LLC
NEW YORK, NY · Quarter end: Jun 30, 2026 · Filed with SEC: Aug 17, 2026 · Open the SEC source ↗
Portfolio Return (1Y)——
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.$4.05B2026 Q2+ $13.0M options (notional, not included)
Positions562
Top-10 ConcentrationPercent of the portfolio in the 10 largest holdings. High means the fund is concentrated in few stocks.38.6%
What Changed This Quarter?
Top Holdings
Janus Henders…
Janus Henderson
8.0%
NUVLEUR
Nuvalent
5.4%
Apogee Therap…
Apogee Therapeutics
5.4%
BLD*
Topbuild Cor
5.2%
SEMEUR
Select Med
4.4%
CPRXEUR
Catalyst Pharmaceuticals
2.8%
HBM
Hudbay Minerals
2.1%
DBRG
DigitalBridge
1.9%
New / Increased
196 new · 111 increased
NUVLEURNEW
Nuvalent
5.4%
Apogee Therap…NEW
Apogee Therapeutics
5.4%
BLD*NEW
Topbuild Cor
5.2%
CPRXEURNEW
Catalyst Pharmaceuticals
2.8%
HBMNEW
Hudbay Minerals
2.1%
Janus Henders…
Janus Henderson
8.0%
+813.8%
SEMEUR
Select Med
4.4%
+163.3%
WED
Webster Financial
1.7%
+646.4%
Read the 2026-Q2 quarterly report · 13F Filing Calendar
13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.